Pfizer Partners DPIIT to Strengthen India's Healthcare Innovation Drive

The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has partnered with Pfizer Limited by signing a Memorandum of Understanding (MoU) to help the healthcare innovation landscape of India. 

The association was arrived at to provide both financial and strategic efforts that would onboard the startups, thus considerably shortening the lab-to-market journey of game-changing healthcare solutions. 

This move is primarily centered on the Pfizer’s INDovation program meant to invite a grant for the DPIIT approved startups up to ?60 lakhs each. Services such as expert guidance, infrastructure and the access to Pfizer’s worldwide connections, including their R&D premises in Chennai, are free of charge to the attendees.

This program aims to support 14 innovative MedTech startups that are on the verge of working on the areas of diagnostics, screening, health monitoring, oncology, brain health, maternal and child health, immunization, and non-communicable diseases. 

Also Read: Granules, NIPER Launch Centre for Green Pharma Innovation

While addressing the concerns at the signing event, Sanjiv, Joint Secretary, DPIIT, said that the focus should be on new drug discovery as well as on the participation of startups. Sharad Goswami, Senior Director – Global Policy and Public Affairs, Pfizer India, declared Pfizer’s commitment to supporting patient-centric innovations that would be the way to scalable solutions.